慢性肾脏病患者疲乏的研究

注册号:

Registration number:

ChiCTR2500098623 

最近更新日期:

Date of Last Refreshed on:

2025-03-11 15:46:33 

注册时间:

Date of Registration:

2025-03-11 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

慢性肾脏病患者疲乏的研究

Public title:

A study of fatigue in patients with chronic kidney disease

注册题目简写:

English Acronym:

研究课题的正式科学名称:

慢性肾脏病患者疲乏的研究

Scientific title:

A study of fatigue in patients with chronic kidney disease

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张娜 

研究负责人:

柳丰萍 

Applicant:

Na Zhang 

Study leader:

Fengping Liu 

申请注册联系人电话:

Applicant telephone:

+86 187 2672 2155

研究负责人电话:

Study leader's
telephone:

+86 136 0619 5202

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

6232807045@stu.jiangnan.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

liulaoshiyc@jiangnan.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

江苏省无锡市梁溪区中山路68号

研究负责人通讯地址:

江苏省无锡市梁溪区中山路68号

Applicant address:

68 Zhongshan Road, Liangxi District, Wuxi, Jiangsu

Study leader's address:

68 Zhongshan Road, Liangxi District, Wuxi, Jiangsu

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

江南大学

Applicant's institution:

Jiangnan University (Jiangsu Province)

研究负责人所在单位:

无锡市第二人民医院

Affiliation of the Leader:

Wuxi Second People's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2024)伦理审查第(Y-245)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

无锡市第二人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of Wuxi Second People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2024-09-26 00:00:00

伦理委员会联系人:

夏加增

Contact Name of the ethic committee:

Xia Jiazeng

伦理委员会联系地址:

江苏省无锡市梁溪区中山路68号

Contact Address of the ethic committee:

68 Zhongshan Road, Liangxi District, Wuxi, Jiangsu

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 151 5222 0089

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

无锡市第二人民医院

Primary sponsor:

Wuxi Second People's Hospital

研究实施负责(组长)单位地址:

江苏省无锡市梁溪区中山路68号

Primary sponsor's address:

68 Zhongshan Road, Liangxi District, Wuxi, Jiangsu

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏

市(区县):

无锡

Country:

China

Province:

Jiangsu

City:

Wuxi

单位(医院):

无锡市第二人民医院

具体地址:

江苏省无锡市梁溪区中山路68号

Institution
hospital:

Wuxi Second People's Hospital

Address:

68 Zhongshan Road, Liangxi District, Wuxi, Jiangsu

经费或物资来源:

“太湖人才计划”医疗卫生领军人才

Source(s) of funding:

Leading medical and health talents of 'Taihu Talents Plan'

研究疾病:

慢性肾脏病  

Target disease:

Chronic kidney disease

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

探索以家庭为中心的赋能护理对慢性肾脏病患者疲乏的影响。  

Objectives of Study:

Exploring the impact of family-centered empowerment care on fatigue in patients with chronic kidney disease.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

患者排除标准 (1) 患有严重精神障碍疾病者; (2) 有恶性肿瘤等合并其他严重疾病的患者; (3) 无照顾者陪同者。 照顾者排除标准 (1) 伴有严重慢性病且病情不稳定者; (2) 已参加过相关培训者。

Exclusion criteria:

Patient exclusion criteria (1) Those with severe mental disorder diseases; (2) Those with malignant tumors or other serious diseases in combination; (3) Those who are not accompanied by a caregiver. Exclusion Criteria for Caregivers (1) Those with serious chronic diseases and unstable conditions; (2) Those who have participated in relevant training.

研究实施时间:

Study execute time:

From 2025-04-01 00:00:00 To 2025-11-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-04-01 00:00:00 To 2025-09-30 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

37

Group:

Control subjects

Sample size:

干预措施:

常规护理和宣教:由责任护士向患者讲解与疾病相关的知识(如:降压药物的合理使用、饮水控制、体重管理等)、监测记录患者的生命体征、观察与护理患者的病情。

干预措施代码:

Intervention:

Routine nursing care and education: the nurse-in-charge will explain to the patient the knowledge related to the disease (e.g., rational use of antihypertensive drugs, water control, weight management, etc.), monitor and record the patient's vital signs, and observe and care for the patient's condition.

Intervention code:

组别:

干预组

样本量:

37

Group:

Intervention group

Sample size:

干预措施:

干预组在常规护理的基础上,实施以家庭为中心的赋权教育干预。

干预措施代码:

Intervention:

The intervention group implemented a family-centered empowerment education intervention based on usual care.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏 

市(区县):

无锡 

Country:

China

Province:

Jiangsu

City:

Wuxi

单位(医院):

无锡市第二人民医院 

单位级别:

三级甲等 

Institution
hospital:

Wuxi Second People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

Piper疲乏修订版量表中文版评分

指标类型:

主要指标

Outcome:

The Revised Piper Fatigue Scale Score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

慢性病自我效能量表评分

指标类型:

次要指标

Outcome:

Self-efficacy for Chronic Disease Scale Score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

家庭关怀度指数量表评分

指标类型:

次要指标

Outcome:

Family APGAR Index Score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

医学应对方式量表评分

指标类型:

次要指标

Outcome:

Medical Coping Mode Questionnaire Score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

社会支持量表评分

指标类型:

次要指标

Outcome:

Social Support Rating Scale Score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

焦虑自评量表评分

指标类型:

次要指标

Outcome:

Self-rating Anxiety Scale Score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

抑郁自评量表评分

指标类型:

次要指标

Outcome:

Self-rating Depression Scale Score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用随机数字表法,将研究对象按照1:1的比例随机分为干预组和对照组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Using random number table method, the study subjects were randomly divided into intervention and control groups in the ratio of 1:1.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

由第三者采用纸质问卷调查表记录患者一般信息,各种测量指标数据由专人记录成电子文档。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

A third party used a paper questionnaire to record the general information of the patients, and the data of various measurements were recorded into electronic documents by a special person.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2025-03-11 15:46:21